Geriatric Acetabular FracTures: Open Reduction Internal Fixation Versus Replacement
Launched by UNITY HEALTH TORONTO · Oct 18, 2018
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to best treat hip fractures in older adults, specifically looking at two different surgical options: one that uses plates and screws to fix the fracture (called open reduction internal fixation or ORIF) and another that combines this fixation with a total hip replacement. The goal is to find out which method helps reduce pain and improve physical function for patients aged 60 and older who have recently suffered an acetabular fracture, which is a break in the hip joint.
To be part of this study, participants need to be 60 years or older, have a specific type of hip fracture that requires surgery, and were able to walk before the injury. The study will not include individuals with certain infections, severe fractures, or conditions like dementia. Those who join can expect to receive one of the two surgical treatments and participate in assessments of their pain and ability to move. This research is important because it aims to improve outcomes for older adults facing the challenges of hip fractures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 60 years of age or older
- • Isolated and Displaced (more or equal to 2mm on any radiographic view) fracture of the acetabulum
- • Patient requires surgical treatment, either THA+ORIF or ORIF surgeries
- • Fracture is acute (within 3 weeks of injury)
- • Patient was ambulatory (with or without walking aids) prior to their acetabular fracture injury
- • Patient is able to provide informed consent to participation in the study
- • Patient is able to read and understand English
- Exclusion Criteria:
- • Presence of an active or chronic infection around the fracture (soft tissue or bone)
- • Open/compound fracture
- • Bilateral acetabular fractures
- • Pathological fracture excluding osteoporosis
- • Periprosthetic fracture (previous arthroplasty or hardware or ORIF in-situ). Hardware (screws or plates or nails or hemi-arthroplasty) on the femoral side are not excluded.
- • Medical or surgical contraindication to surgery
- • Dementia
About Unity Health Toronto
Unity Health Toronto is a leading healthcare organization dedicated to providing exceptional patient care, advancing medical research, and fostering education in the field of health sciences. Comprising St. Michael's Hospital, St. Joseph's Health Centre, and Providence Healthcare, Unity Health integrates a diverse range of clinical services and innovative research initiatives. The organization is committed to improving health outcomes through collaborative partnerships and community engagement, while upholding the highest standards of ethics and integrity in its clinical trials and research endeavors. By focusing on patient-centered approaches, Unity Health Toronto aims to drive advancements in healthcare and contribute to the well-being of the communities it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Amir Khoshbin, MD
Principal Investigator
Unity Health Toronto
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials